申请人:G1 Therapeutics, Inc.
公开号:US10208011B2
公开(公告)日:2019-02-19
This invention is a benzothiophene estrogen receptor modulator or its pharmaceutically acceptable salt or a pharmaceutically acceptable composition thereof to treat an estrogen-related medical disorder.
本发明是一种苯并噻吩雌激素受体调节剂或其药学上可接受的盐或其药学上可接受的组合物,用于治疗与雌激素相关的疾病。